Integrated Filing — IndAS



General information about company

Scrip Code 533121
NSE Symbol EXPLEOSOL
MSEI Symbol NOTLISTED
ISIN INE201K01015
Name of company Expleo Solutions Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 13-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 05-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Software Validation and Verification Services, Software Development and Engineering consultancy services
Start date and time of board meeting 13-05-2026   11:00:00
End date and time of board meeting 13-05-2026   16:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 24-04-2026
Indicate Company website link for updated RPT policy of the Company https://investors.expleo.com/corporate-governance/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NIL



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 24,654.20 93,905.80
Other income 1,013.10 2,972.60
Total income 25,667.30 96,878.40
2 Expenses
(a) Cost of materials consumed 416.40 1,450.20
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 15,883.80 59,427.60
(e) Finance costs 57.30 223.50
(f) Depreciation, depletion and amortisation expense 574.60 2,752.80
(f) Other Expenses
1 Other Expenses 4,518.00 18,268.30
Total other expenses 4,518.00 18,268.30
Total expenses 21,450.10 82,122.40
3 Total profit before exceptional items and tax 4,217.20 14,756.00
4 Exceptional items 206.00 (1,472.80)
5 Total profit before tax 4,423.20 13,283.20
6 Tax expense
7 Current tax 359.60 2,829.10
8 Deferred tax 484.60 434.90
9 Total tax expenses 844.20 3,264.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 3,579.00 10,019.20
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 3,579.00 10,019.20
17 Other comprehensive income net of taxes 325.90 546.60
18 Total Comprehensive Income for the period 3,904.90 10,565.80
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,552.00 1,552.00
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 65,227.70
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 23.06 64.56
Diluted earnings (loss) per share from continuing operations 23.06 64.56
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 23.06 64.56
Diluted earnings (loss) per share from continuing and discontinued operations 23.06 64.56
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 7,179.00
Capital work-in-progress 0.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 49.40
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 0.00
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Investments in subsidiaries 562.30
2 Other Financial Assets 409.60
3 - 0.00
4 - 0.00
5 - 0.00
Total of other non-current financial assets 971.90
Total non-current financial assets 971.90
Deferred tax assets (net) 732.80
Other non-current assets
1 Income Tax Assets (Net) 2,361.80
2 Other Non Current Assets 1,139.10
3 - 0.00
4 - 0.00
5 - 0.00
Total of other non-current assets 3,500.90
Total non-current assets 12,434.00
2 Current assets
Inventories 0.00
Current financial asset
Current investments 0.00
Trade receivables, current 23,867.10
Cash and cash equivalents 32,368.30
Bank balance other than cash and cash equivalents 2,149.70
Loans, current 0.00
Other current financial assets
Total of other current financial assets 5,792.70
Total current financial assets 64,177.80
Current tax assets (net) 0.00
Other current assets
1 Other Current Assets 2,805.20
2 - 0.00
3 - 0.00
4 - 0.00
5 - 0.00
Total of other current assets 2,805.20
Total current assets 66,983.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 79,417.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,552.00
Other equity 65,227.70
Total equity attributable to owners of parent 66,779.70
Non controlling interest
Total equity 66,779.70
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease liabilities 505.80
2 - 0.00
3 - 0.00
4 - 0.00
5 - 0.00
Total of other non-current financial liabilities 505.80
Total non-current financial liabilities 505.80
Provisions, non-current 1,802.30
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 - 0.00
2 - 0.00
3 - 0.00
4 - 0.00
5 - 0.00
Total of other non-current liabilities 0.00
Total non-current liabilities 2,308.10
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 57.60
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 4,284.10
Total Trade payable 4,341.70
Other current financial liabilities
1 Lease liabilities 279.40
2 Other Current Financial Liabilities 1,959.30
3 - 0.00
4 - 0.00
5 - 0.00
Total of other current financial liabilities 2,238.70
Total current financial liabilities 6,580.40
Other current liabilities 1,814.60
1 Other Current Liabilities 1,814.60
2 - 0.00
3 - 0.00
4 - 0.00
5 - 0.00
Total of other current liabilities 1,814.60
Provisions, current 1,243.00
Current tax liabilities (Net) 691.20
Deferred government grants, Current 0.00
Total current liabilities 10,329.20
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 12,637.30
Total equity and liabilites 79,417.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit or loss 348.70 268.20
Total Amount of items that will not be reclassified to profit and loss 348.70 268.20
2 Income tax relating to items that will not be reclassified to profit or loss 87.80 67.50
3 Amount of items that will be reclassified to profit and loss
1 Exchange difference on translation of foreign operations 65.00 345.90
Total Amount of items that will be reclassified to profit and loss 65.00 345.90
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 325.90 546.60



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 13,283.20
Adjustments for reconcile profit (loss)
Adjustments for finance costs 223.50
Adjustments for decrease (increase) in inventories 0.00
Adjustments for decrease (increase) in trade receivables, current 3,509.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 1,597.70
Adjustments for decrease (increase) in other non-current assets (675.80)
Adjustments for other financial assets, non-current 258.90
Adjustments for other financial assets, current 65.50
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 681.40
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 45.80
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 2,752.80
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 250.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (1,896.70)
Adjustments for other financial liabilities, non-current (1,204.40)
Adjustments for unrealised foreign exchange losses gains (85.20)
Adjustments for dividend income 0.00
Adjustments for interest income 492.40
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (553.90)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 1,171.80
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 5,648.00
Net cash flows from (used in) operations 18,931.20
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 3,665.70
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 15,265.50
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 214.10
Proceeds from sales of property, plant and equipment 1.20
Purchase of property, plant and equipment 251.20
Proceeds from sales of investment property 0.00
Purchase of investment property 591.10
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 268.20
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities (787.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 745.10
Dividends paid 0.00
Interest paid 200.40
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (945.50)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 13,533.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents (510.40)
Net increase (decrease) in cash and cash equivalents 13,022.60
Cash and cash equivalents cash flow statement at beginning of period 19,345.70
Cash and cash equivalents cash flow statement at end of period 32,368.30





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s. Deloitte Haskins & Sells Yes 30-04-2028


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Expleo Solutions Limited Expleo Technology Ireland Limited Entities under common control Sale of goods or services 4,109.90 Approved 4,109.90 1,942.60 2,160.90
2 Expleo Solutions Limited Expleo Technology Germany GmbH Holding Company Sale of goods or services 3,191.90 Approved 3,191.90 1,574.10 1,620.00
3 Expleo Solutions Limited Expleo Group Austria GmbH Fellow Subsidiaries Sale of goods or services 984.40 Approved 984.40 512.70 490.20
4 Expleo Solutions Limited Expleo Technology Switzerland AG Entities under common control Sale of goods or services 0.00 Approved 0.00 7.40 9.20
5 Expleo Solutions Limited Expleo Technology Belgium SRL Entities under common control Sale of goods or services 27.30 Approved 27.30 0.00 15.80
6 Expleo Solutions Limited Expleo USA Inc Entities under common control Sale of goods or services 291.50 Approved 291.50 181.40 69.80
7 Expleo Solutions Limited Moorhouse Consulting Limited Entities under common control Sale of goods or services 15.90 Approved 15.90 4.90 5.50
8 Expleo Solutions Limited Expleo Germany GmbH Entities under common control Sale of goods or services 1,282.40 Approved 1,282.40 666.10 651.20
9 Expleo Solutions Limited Expleo South Africa Pty Entities under common control Sale of goods or services 16.00 Approved 16.00 4.20 3.40
10 Expleo Solutions Limited Expleo France SASU Entities under common control Sale of goods or services 3,183.50 Approved 3,183.50 1,896.50 1,636.50
11 Expleo Solutions Limited EXPLEO SERVICES SASU Entities under common control Sale of goods or services 1,785.30 Approved 1,785.30 914.80 851.80
12 Expleo Solutions Limited EXPLEO ROMANIA SRL Entities under common control Sale of goods or services 1.00 Approved 1.00 0.00 1.00
13 Expleo Solutions Limited Expleo Technology Nordic AB Entities under common control Sale of goods or services 278.70 Approved 278.70 46.80 57.10
14 Expleo Solutions Limited Group Expleo Technology Belgium SPRL Entities under common control Sale of goods or services 181.90 Approved 181.90 109.20 60.00
15 Expleo Solutions Limited Expleo Technology UK Limited Fellow Subsidiaries Sale of goods or services 1,817.20 Approved 1,817.20 991.50 909.00
16 Expleo Solutions Limited Expleo Netherlands B.V. Fellow Subsidiaries Sale of goods or services 197.70 Approved 197.70 108.50 87.00
17 Expleo Solutions Limited Expleo Technology USA Inc Fellow Subsidiaries Sale of goods or services 375.40 Approved 375.40 135.50 192.10
18 Expleo Solutions Limited Expleo Engineering UK Limited Entities under common control Sale of goods or services 757.40 Approved 757.40 481.40 672.60
19 Expleo Solutions Limited Expleo Portugal Entities under common control Sale of goods or services 165.10 Approved 165.10 44.60 97.10
20 Expleo Solutions Limited Expleo Regions SASU Entities under common control Sale of goods or services 18.50 Approved 18.50 (0.20) 0.00
21 Expleo Solutions Limited SILVER ATENA GmbH Entities under common control Sale of goods or services 238.30 Approved 238.30 175.60 103.30
22 Expleo Solutions Limited Stirling Dynamics Entities under common control Sale of goods or services 5.40 Approved 5.40 6.50 1.90
23 Expleo Solutions Limited Expleo Nordics Entities under common control Sale of goods or services 0.00 Approved 0.00 0.00 0.00
24 Expleo Solutions Limited Expleo Technology Egypt Entities under common control Sale of goods or services 15.80 Approved 15.80 21.40 183.00
25 Expleo Solutions Limited Assystem Brime Engineering Consulting Shanghai Co Ltd Entities under common control Sale of goods or services 0.00 Approved 0.00 0.00 0.00
26 Expleo Solutions Limited Expleo Canada Entities under common control Sale of goods or services 154.50 Approved 154.50 23.10 10.90
27 Expleo Solutions Limited Expleo Iberia S.L.U Entities under common control Sale of goods or services 4.50 Approved 4.50 (2.80) 0.00
28 Expleo Solutions Limited Expleo Solutions Pte. Ltd Subsidiary Sale of goods or services 487.90 Approved 487.90 364.60 85.10
29 Expleo Solutions Limited Expleo Solutions Inc Subsidiary Sale of goods or services 1,974.50 Approved 1,974.50 3,836.30 2,773.40
30 Expleo Solutions Limited Expleo Solutions LLC Subsidiary Sale of goods or services 755.50 Approved 755.50 1,753.20 1,637.70
31 Expleo Solutions UK Limited Expleo Technology UK Limited Fellow Subsidiaries Sale of goods or services 217.00 Approved 217.00 102.10 150.40
32 Expleo Solutions LLC Moorhouse Consulting Limited Entities under common control Sale of goods or services 55.80 Approved 55.80 0.00 0.00
33 Expleo Solutions Limited Group Expleo Technology Belgium Entities under common control Purchase of goods or services 424.10 Approved 424.10 245.80 91.80
34 Expleo Solutions Limited EXPLEO FRANCE SASU Entities under common control Purchase of goods or services 916.60 Approved 916.60 618.80 525.70
35 Expleo Solutions Limited EXPLEO SERVICES SASU Entities under common control Purchase of goods or services 0.00 Approved 0.00 1.10 0.00
36 Expleo Solutions Limited Expleo Technology Egypt Fellow Subsidiaries Purchase of goods or services 58.30 Approved 58.30 41.20 25.30
37 Expleo Solutions Limited Expleo Technology USA Inc Entities under common control Purchase of goods or services 234.30 Approved 234.30 153.80 115.50
38 Expleo Solutions Limited Expleo Iberia S.L.U Entities under common control Purchase of goods or services 1.50 Approved 1.50 0.00 0.00
39 Expleo Solutions Limited Expleo Services-Espace Entities under common control Purchase of goods or services 2,557.80 Approved 2,557.80 14.60 667.70
40 Expleo Solutions Limited Expleo Technology Germany GmbH Holding Company Purchase of goods or services 6.50 Approved 6.50 0.00 0.00
41 Expleo Solutions Limited Moorhouse Consulting Ltd Entities under common control Purchase of goods or services 140.10 Approved 140.10 25.20 59.10
42 Expleo Solutions Limited Expleo Israel Ltd Entities under common control Purchase of goods or services 53.00 Approved 53.00 0.00 47.70
43 Expleo Solutions Limited Expleo Solutions Arabia Limited Subsidiary Purchase of goods or services 247.90 Approved 247.90 25.40 43.70
44 Expleo Solutions Limited Expleo Solutions UK Ltd Subsidiary Purchase of goods or services 932.40 Approved 932.40 0.00 192.10
45 Expleo Solutions Inc Expleo Technology USA, Inc Fellow Subsidiaries Purchase of goods or services 39.40 Approved 39.40 3.30 21.10
46 Expleo Solutions Inc EXPLEO ROMANIA SRL Entities under common control Purchase of goods or services 47.70 Approved 47.70 24.40 26.50
47 Expleo Solutions Inc Expleo France SASU Entities under common control Purchase of goods or services 6.60 Approved 6.60 0.00 10.80
48 Expleo Solutions Inc Expleo USA Inc Entities under common control Purchase of goods or services 5.70 Approved 5.70 20.50 0.00
49 Expleo Solutions UK Limited Expleo Technology UK Limited Fellow Subsidiaries Purchase of goods or services 522.70 Approved 522.70 1,478.30 439.90
50 Expleo Solutions UK Limited Expleo Technology Germany GmbH Holding Company Purchase of goods or services 13.90 Approved 13.90 6.50 7.50
51 Expleo Solutions UK Limited Expleo Iberia S.L.U Entities under common control Purchase of goods or services 529.90 Approved 529.90 342.20 341.30
52 Expleo Solutions UK Limited Expleo South Africa (PTY) Ltd Entities under common control Purchase of goods or services 9.20 Approved 9.20 0.00 6.20
53 Expleo Solutions UK Limited SQS PORTUGAL Lda Entities under common control Purchase of goods or services 481.70 Approved 481.70 280.20 256.00
54 Expleo Solutions UK Limited EXPLEO SERVICES SASU Entities under common control Interest received 185.20 Approved 185.20 136.60 67.00
55 Expleo Solutions Pte Limited EXPLEO SERVICES SASU Entities under common control Interest received 42.90 Approved 42.90 22.30 21.80
56 Expleo Solutions Inc EXPLEO SERVICES SASU Entities under common control Interest received 219.60 Approved 219.60 115.10 110.90
57 Expleo Solutions Limited Periakaruppan Palaniappan Chief Financial Officer Remuneration 86.30 Approved 86.30 29.80 10.20
58 Expleo Solutions Limited S Sampathkumar Company Secretary and Compliance Officer Remuneration 26.40 Approved 26.40 6.80 2.10
59 Expleo Solutions Limited Phani Tangirala Managing Director and CEO Remuneration 120.60 Approved 120.60 52.70 16.90
60 Expleo Solutions Limited Mr. Narayanan Subramaniam Independent Director Any other transaction Sitting fees 2.00 Approved 2.00 0.00 0.00
61 Expleo Solutions Limited Dr. Varadharajan Sridhar Independent Director Any other transaction Sitting fees 1.80 Approved 1.80 0.00 0.00
62 Expleo Solutions Limited Dr. Srivardhini Keshavamurthy Jha Independent Director Any other transaction Sitting fees 1.80 Approved 1.80 0.00 0.00
63 Expleo Solutions Limited Ms. Shalini Kalsi Kamath Independent Director Any other transaction Sitting fees 1.80 Approved 1.80 0.00 0.00
64 Expleo Solutions Limited Mr. Narayanan Subramaniam Independent Director Any other transaction Commission 18.40 Approved 18.40 15.00 33.40
65 Expleo Solutions Limited Dr. Varadharajan Sridhar Independent Director Any other transaction Commission 18.40 Approved 18.40 15.00 33.40
66 Expleo Solutions Limited Dr. Srivardhini Keshavamurthy Jha Independent Director Any other transaction Commission 18.40 Approved 18.40 15.00 33.40
67 Expleo Solutions Limited Ms. Shalini Kalsi Kamath Independent Director Any other transaction Commission 18.40 Approved 18.40 15.00 33.40
68 Expleo Solutions Limited Expleo Solutions Inc Subsidiary Investment 0.00 Approved 0.00 46.20 46.20
69 Expleo Solutions Limited Expleo Solutions LLC Subsidiary Investment 0.00 Approved 0.00 33.70 33.70
70 Expleo Solutions Limited Expleo Solutions Pte. Ltd Subsidiary Investment 0.00 Approved 0.00 26.60 26.60
71 Expleo Solutions Limited Expleo Solutions UK Ltd Subsidiary Investment 0.00 Approved 0.00 241.70 241.70
72 Expleo Solutions Limited Expleo Solutions Arabia Limited Subsidiary Investment 0.00 Approved 0.00 214.20 214.20
73 Expleo Solutions UK Limited EXPLEO SERVICES SASU Entities under common control Loan (3,014.80) Approved (3,014.80) 5,959.20 3,106.80 Loan 9.3600 3 YEARS Unsecured Business purposes Textual Information(1)
74 Expleo Solutions Pte Limited EXPLEO SERVICES SASU Entities under common control Loan 0.00 Approved 0.00 1,374.10 1,459.70 Loan 7.3100 3 YEARS Unsecured Business purposes Textual Information(2)
75 Expleo Solutions Inc EXPLEO SERVICES SASU Entities under common control Loan 0.00 Approved 0.00 4,879.90 5,179.70 Loan 9.2300 3 YEARS Unsecured Business purposes Textual Information(3)
76 Expleo Solutions Limited Expleo France SASU Entities under common control Any other transaction Prepaid balance 71.80 Approved 71.80 0.00 71.80
77 Expleo Solutions Limited Expleo Technology Germany GmbH Holding Company Any other transaction Prepaid balance 1.30 Approved 1.30 0.00 1.30
78 Expleo Solutions UK Limited Expleo Technology UK Limited Fellow Subsidiaries Any other transaction Prepaid balance 15.70 Approved 15.70 0.00 15.70
79 Expleo Solutions Inc Expleo France SASU Entities under common control Any other transaction Prepaid balance 3.90 Approved 3.90 0.00 3.90
80 Expleo Solutions Inc Expleo Technology USA, Inc Fellow Subsidiaries Any other transaction Prepaid balance 1.20 Approved 1.20 0.00 1.20
Total value of transaction during the reporting period 27,660.60



Text Block

Textual Information(1) Loan Repayment GBP 2.5Mn during the H2 period. Forex revaluation leads to further movement.
Textual Information(2) No movement other than, Forex revaluation.
Textual Information(3) No movement other than, Forex revaluation.